首页 | 本学科首页   官方微博 | 高级检索  
检索        

美洛西林钠舒巴坦钠联合喜炎平治疗中老年社区获得性肺炎的疗效观察
引用本文:杨维建.美洛西林钠舒巴坦钠联合喜炎平治疗中老年社区获得性肺炎的疗效观察[J].中国民康医学,2013(2):10+63-10,63.
作者姓名:杨维建
作者单位:成都市德康医院
摘    要:目的:观察美洛西林钠舒巴坦钠联合喜炎平治疗中老年社区获得性肺炎的疗效。方法:将97例中老年社区获得性肺炎患者随机分组。治疗组49例,采用美洛西林钠舒巴坦钠联合喜炎平治疗。对照组48例,单用美洛西林钠舒巴坦钠治疗。结果:治疗组总有效率8775%,对照组总有效率68.75%,两组疗效有显著性差异(P〈0.05)。治疗组治疗住院时间缩短(t=6.79,P〈0.01)。两组不良反应发生率分别为8.16%和6.25%(P〉0.05)。结论:喜炎平具有抗病毒、抗菌、清热解毒等多重作用,治疗中老年社区获得性肺炎安全、有效。

关 键 词:肺炎  中老年  美洛西林钠舒巴坦钠  喜炎平注射液

Curative effect observation of Mezlocillin sodium and Sulbactam sodium combined with Xiyanping in the treatment of elderly patients with community acquired pneumonia
YANG Wei-jian.Curative effect observation of Mezlocillin sodium and Sulbactam sodium combined with Xiyanping in the treatment of elderly patients with community acquired pneumonia[J].medical journal of chinese peoples health,2013(2):10+63-10,63.
Authors:YANG Wei-jian
Institution:YANG Wei-jian(Chengdu Dekang Hospital,Chengdu 610091,China)
Abstract:Objective:To observe the Curative effect of Mezlocillin sodium and Sulbactam sodium combined with Xiyanping in the treatment of elderly patients with community acquired pneumonia. Methods : 97 elderly patients with community acquired pneumonia were randomly divided into treat- ment group(49 cases) and control group(48 cases). The treatment group used Mezlocillin sodium and Sulbactam sodium combined with Xiyanping. The- control group only used Mezlocillin sodium and Sulbactam sodium. Results: The total effective rate of treatment group 87.75% ;control group in the total efficiency of 68.75%. The effect of two groups had significant difference( P 〈 0.05 ). The treatment group hospitalization time was shortened( t = 6.79, P 〈 0.01 ). Two groups of the incidence of adverse reactions were 8.16% and 6.25% ( P 〉 0.0.5 ). Conclusion : Xiyanping has antiviral, antibacterial, clearing heat and removing toxicitymultiple roles,is safe and effective for treatment of elderly patients with community acquired pneumonia.
Keywords:Pneumonia  Elderly  Mezloeillin sodium and Sulbaetamsodium  Xiyanping injection
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号